AgomAb Therapeutics NV Statistics
Total Valuation
AGMB has a market cap or net worth of $447.17 million. The enterprise value is $160.60 million.
| Market Cap | 447.17M |
| Enterprise Value | 160.60M |
Important Dates
The next estimated earnings date is Saturday, November 14, 2026, before market open.
| Earnings Date | Nov 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AGMB has 49.25 million shares outstanding. The number of shares has increased by 3,716.54% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 49.25M |
| Shares Change (YoY) | +3,716.54% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.16% |
| Owned by Institutions (%) | 44.32% |
| Float | 13.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.51 |
| P/TBV Ratio | 6.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.88, with a Debt / Equity ratio of 0.00.
| Current Ratio | 12.88 |
| Quick Ratio | 12.55 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -329.71 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -24.35% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.50M |
| Employee Count | 62 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 12.54 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 34.79 |
| Average Volume (20 Days) | 168,996 |
Short Selling Information
The latest short interest is 867,701, so 2.46% of the outstanding shares have been sold short.
| Short Interest | 867,701 |
| Short Previous Month | 878,372 |
| Short % of Shares Out | 2.46% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 6.13 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -75.34M |
| Pretax Income | -76.15M |
| Net Income | -93.23M |
| EBITDA | -74.90M |
| EBIT | -75.34M |
| Earnings Per Share (EPS) | -$4.51 |
Balance Sheet
The company has $287.88 million in cash and $1.30 million in debt, with a net cash position of $286.57 million or $5.82 per share.
| Cash & Cash Equivalents | 287.88M |
| Total Debt | 1.30M |
| Net Cash | 286.57M |
| Net Cash Per Share | $5.82 |
| Equity (Book Value) | 303.18M |
| Book Value Per Share | 2.59 |
| Working Capital | 272.38M |
Cash Flow
In the last 12 months, operating cash flow was -$63.55 million and capital expenditures -$4,481, giving a free cash flow of -$63.55 million.
| Operating Cash Flow | -63.55M |
| Capital Expenditures | -4,481 |
| Depreciation & Amortization | 426,461 |
| Net Borrowing | -379,782 |
| Free Cash Flow | -63.55M |
| FCF Per Share | -$1.29 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AGMB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3,716.54% |
| Shareholder Yield | n/a |
| Earnings Yield | -20.85% |
| FCF Yield | -14.21% |
Analyst Forecast
The average price target for AGMB is $37.67, which is 314.87% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $37.67 |
| Price Target Difference | 314.87% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |